EUVIMEDEUVIMED entdecken
Crossref

Cyp2e1 protects against OVA-induced allergic rhinitis through the inhibition of Th2 cell activation and differentiation: Mediated by MAFB

Weiliang Bai, Hui Su, Shengqun Xu, Zhao Gao, Ziwen Chang, Xun Sun, Tiancong Liu

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Weiliang Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, PR China. Hauptthemen laut MEDLINE: Cell Differentiation, Cytochrome P-450 CYP2E1, Nasal Mucosa, Ovalbumin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allergic rhinitis (AR) is a common allergic disease. Cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp2e1) is a member of the cytochrome P450 family of enzymes, while its role in AR is still unveiled. In AR mice, T cell-specific overexpression of Cyp2e1 relieved the AR symptoms. Overexpressed-Cyp2e1 restrained the infiltration of eosinophils and mast cells in the nasal mucosa of mice, and the inflammatory cells in nasal lavage fluid (NALF). Cyp2e1 overexpressed mice exhibited decreased goblet cell hyperplasia and mucus secretion as well as decreased MUC5AC expression in nasal mucosa. The epithelial permeability and integrity of nasal mucosa were improved upon Cyp2e1 overexpression in AR mice, as evidenced by decreased fluorescein isothiocyanate-dextran 4 content in serum, increased expression of IL-25, IL-33, and TSLP in NALF, and increased expression of ZO-1 and occluding in nasal mucosa. Cyp2e1 inhibited Th2 immune response by decreasing the expression and secretion of IL-4, IL-5, and IL-13 as well as the expression of GATA-3 in NALF or nasal mucosa. We proved that Cyp2e1 inhibited the differentiation of naïve CD4+ T cells toward the Th2 subtype, which was regulated by MAFB by binding to Cyp2e1 promoter to activate its transcription. Overall, these results show the potential role of Cyp2e1 in alleviating AR symptoms by restraining CD4+ T cells to Th2 cell differentiation. Our findings provide further insight into the AR mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationCytochrome P-450 CYP2E1Nasal MucosaOvalbuminRhinitis, AllergicTh2 CellsAnimalsHumansMiceCytokinesDisease Models, AnimalLymphocyte ActivationMice, Inbred BALB CMafB Transcription Factor

Stichwörter der Autor:innen

Allergic rhinitisCyp2e1MAFBTh2 cell differentiation

Substanzen

Cytochrome P-450 CYP2E1CytokinesOvalbumincytochrome P-450 2E1, mouseMafb protein, mouseMafB Transcription Factor

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, PR China.
  • Department of Immunology, College of Basic Medicine, China Medical University, Shenyang, PR China.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, PR China. Electronic address: tcliu@cmu.edu.cn.

Zitieren

APA

Bai, W., Su, H., Xu, S., Gao, Z., Chang, Z., Sun, X., & Liu, T. (2024). Cyp2e1 protects against OVA-induced allergic rhinitis through the inhibition of Th2 cell activation and differentiation: Mediated by MAFB. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112003

Vancouver

Bai W, Su H, Xu S, Gao Z, Chang Z, Sun X, et al. Cyp2e1 protects against OVA-induced allergic rhinitis through the inhibition of Th2 cell activation and differentiation: Mediated by MAFB. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112003

BibTeX
@article{Bai2024,
  author = {Bai, Weiliang and Su, Hui and Xu, Shengqun and Gao, Zhao and Chang, Ziwen and Sun, Xun and Liu, Tiancong},
  title = {Cyp2e1 protects against OVA-induced allergic rhinitis through the inhibition of Th2 cell activation and differentiation: Mediated by MAFB},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112003}
}
Kostenlos starten →